Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Long COVID causes various long-term health issues and needs better awareness and treatment.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

A woman experienced vertigo and hearing loss after weight loss surgery, possibly due to eustachian tube issues from fat loss around ear muscles.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

People with polycystic ovary syndrome often experience anxiety and depression.

Most non-medical students at Tarumanagara University have good knowledge and attitudes about PCOS.

FGF13 gene changes cause excessive hair growth in a rare condition.

Vertical sleeve gastrectomy improved metabolism, behavior, and reproduction in obese rats with PCOS.

New hair growth corticosterone levels are higher in diabetic mice, indicating long-term stress.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Some skin diseases and their treatments can negatively affect male fertility.

Nearly all elderly nursing home residents had a skin disease, with dry skin being the most common.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

EtG levels in hair decrease significantly after one month of alcohol abstinence.